Principal Accounting Officer · Altimmune, Inc. · Altimmune, Inc. — Stock Options (option to buy)
Side
A
Value
—
Shares
84.5K
Price
—
Executed
Oct 1, 2026
Disclosed
Oct 2, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 1 executedOct 2, 2026 disclosed
ALT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Menziuso Richard Thomas filed this Form 4 reporting a grant or award of ALT on Oct 1, 2026. It became public on Oct 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Principal Accounting Officer
Menziuso Richard Thomascik:0002156820
Issuer
Altimmune, Inc.cik:0001326190
Revision history · 0
No field has changed since this record was first ingested.
